Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

9 Dec 2023

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed nonalcoholic fatty liver disease (NAFLD), is a widespread global health concern that affects around 25% of the global population. Its influence is expanding, and it is anticipated to overtake alcohol as the leading cause of liver failure and liver-related death worldwide. Unfortunately, there are no approved therapies for MASLD; as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet, Metabolism, and Disease
Share to Liver Disease Diagnosis and Treatment
Share to Mitochondrial Function and Pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38132126
DOI: 10.3390/cells12242806

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)PMID 38132126Read ↗

Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLDSemantic proximity Read ↗

Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read ↗

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?Semantic proximity Read ↗

Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non‐alcoholic fatty liver diseaseSemantic proximity Read ↗

Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulationSemantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatmentSemantic proximity Read ↗

Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease?Semantic proximity Read ↗

The Role and Mechanism of Action of Mitophagy in Various Liver DiseasesSemantic proximity Read ↗

Mitochondrial dynamics, quality control, and mtDNA in alcohol-associated liver disease and liver cancerSemantic proximity Read ↗

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCCSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.